Home›Companies›Jolie Skin

Jolie Skin Company, Inc.

Updated Oct 27, 2026·Latest SEC filing Mar 15, 2023·Suggest an edit

About Jolie Skin

Jolie Skin is a private company based in Accord, New York, incorporated in 2021 in Delaware. It has reported $3,112,800 raised in five offerings on Form D since May 2021. Its chief executive is Ryan Babenzien.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Mar 6, 2023Mar 15, 2023$2,000,000fully sold1$2.0MDebt, Options, Securities on exerciseRule 506(b)Form D ↗
Feb 7, 2022Feb 17, 2022$300,000of $1.3M target1$300KEquity, Securities on exerciseRule 506(b)Form D ↗
Jul 7, 2021Jul 14, 2021$55,000of $500K target2$27,500Securities on exerciseRule 506(b)Form D ↗
May 20, 2021May 27, 2021$500,000fully sold1$500KSecurities on exerciseRule 506(b)Form D ↗
Feb 26, 2021May 26, 2021$257,800of $260K target7$36,829Securities on exerciseRule 506(b)Form D ↗
Total, five offerings$3,112,800

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Jolie Skin's Form D filed Mar 15, 2023.

RD
Rob Dyrdek
Director
RB
Ryan Babenzien
CEO and director
AS
Arjan Singh
Executive officer

Earlier filings also listed Rob Dyrtek (director, last listed Jul 2021).

Sources

  1. SECJOLIE SKIN COMPANY, INC. filing history